Table 1. Summary of the clinical and pathological features of samples included in the study.
| HCC | CC | AC | PDAC | |
|---|---|---|---|---|
| Total Number | No=51 | No=10 | No=5 | No= 37 |
| Age (Mean ±SD) | 57.1±6.8 | 52.5±3.5 | 57.40±7.5 | 54.92±12.91 |
| Gender | ||||
| Male | 42 (82.4%) | 6(60%) | 2(40%) | 25(67.6%) |
| Female | 9 (17.6%) | 4(40%) | 3(60%) | 12(32.4%) |
| Tumor size | ||||
| Mean ±SD | 7.3±13.4 | 7.3±13.4 | 2.5±0.3559 | 3.3±1.2 |
| Tumor grade | ||||
| Grade I | 0 | 0 | 2(40.0%) | 6(16.2%) |
| Grade II | 26(51%) | 7(70%) | 2(40.0%) | 23(62.2%) |
| Grade III | 25(49%) | 3(30%) | 1(20.0%) | 7(18.9%) |
| Grade IV | 0 | 0 | 0 | |
| NA | 1 (2.7%) | |||
| Vascular invasion | 24(47.1%) | 4(40%) | 0 | 10(27.0%) |
HCC: hepatocellular carcinoma, ICC: intrahepatic cholangiocarcinoma, DBD: distal bile duct carcinoma, AC: ampullary carcinoma, PDAC: pancreatic ductal adecarcinoma. NA: a case of signet ring carcinoma (not graded).SD: standard deviation from the mean.